Senestech, Inc. current report, 20 November 2017

SenesTech, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by SenesTech, Inc. on November 21, 2017, covering events occurring on November 20, 2017. The Company, incorporated in Delaware, is reporting an amendment to a material definitive agreement related to a public offering of securities.

Key Financial Metrics

The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a securities offering amendment.

Material Changes and Agreements

On November 20, 2017, the Company entered into an amendment to an Underwriting Agreement dated November 17, 2017, regarding a firm commitment underwritten public offering. Key details include:

  • Offering Structure: The offering consists of 5,400,000 shares of common stock and warrants to purchase 4,050,000 shares of common stock.
  • Underwriters: Roth Capital Partners, LLC (sole book-runner) and Craig-Hallum Capital Group (co-manager).
  • Amendment Terms: Roth Capital Partners will receive warrants to purchase 540,000 shares of common stock as part of its compensation.
  • Warrant Exercise: The warrants may be exercised for $1.50 for one share of common stock and an investor warrant for 0.75 shares of common stock.
  • Additional Shares: If exercised, the Roth warrants would provide an additional 405,000 shares of common stock.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed in the text of this report, other than the standard qualification that the description of the Underwriting Agreement is not complete and is subject to the full text of the exhibits.

Investor Verification Checklist

  • Verify the full terms of the Underwriting Agreement and Amendment in Exhibit 1.1 and Exhibit 1.2.
  • Review the amended form of the Underwriter's Warrant in Exhibit 4.1 to confirm exercise conditions.
  • Confirm the final closing date and total proceeds of the offering, as this 8-K only reports the amendment to the agreement.
  • Check subsequent filings for the actual issuance of the 5,400,000 shares and associated warrants.